Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$778M |
| 2 |
Walt Disney
DIS
|
+$575M |
| 3 |
Amazon
AMZN
|
+$558M |
| 4 |
Applied Materials
AMAT
|
+$373M |
| 5 |
eBay
EBAY
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$669M |
| 2 |
Philip Morris
PM
|
+$454M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 4 |
Marvell Technology
MRVL
|
+$371M |
| 5 |
Qualcomm
QCOM
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.2% |
| 2 | Financials | 10.85% |
| 3 | Healthcare | 9.88% |
| 4 | Industrials | 8.88% |
| 5 | Consumer Discretionary | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Tilray
TLRY
$632M
| $422K | ﹤0.01% |
17,082
+5,620
| +49% | +$108K |
|
|
HEQ
3402
John Hancock Hedged Equity & Income Fund
HEQ
$139M
| $421K | ﹤0.01% |
40,132
+6,723
| +20% | +$68.5K |
|
3403
KT
KT
$8.79B
| $421K | ﹤0.01% |
30,004
-1,035
| -3% | -$14.3K |
|
|
PSTX
3404
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $419K | ﹤0.01% |
131,502
+93,988
| +251% | +$313K |
|
3405
Microvast
MVST
$288M
| $418K | ﹤0.01% |
+499,772
| New | +$446K |
|
3406
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$578M
| $418K | ﹤0.01% |
5,571
| – | – |
|
|
AFB
3407
AllianceBernstein National Municipal Income Fund
AFB
$317M
| $417K | ﹤0.01% |
37,958
+139
| +0.4% | +$1.51K |
|
3408
ProFrac Holding
ACDC
$765M
| $417K | ﹤0.01% |
+49,822
| New | +$383K |
|
3409
Janus International
JBI
$771M
| $415K | ﹤0.01% |
+27,400
| New | +$398K |
|
3410
Aldeyra Therapeutics
ALDX
$93.5M
| $413K | ﹤0.01% |
126,176
-39,752
| -24% | -$131K |
|
3411
Omeros
OMER
$937M
| $412K | ﹤0.01% |
119,446
+2,730
| +2% | +$10.4K |
|
3412
Toast
TOST
$19.6B
| $411K | ﹤0.01% |
16,495
-98,636
| -86% | -$2.04M |
|
3413
Banco de Chile
BCH
$20.9B
| $410K | ﹤0.01% |
+18,229
| New | +$410K |
|
|
AHT
3414
Ashford Hospitality Trust
AHT
$20.7M
| $410K | ﹤0.01% |
29,909
+19,721
| +194% | +$304K |
|
3415
Nomura Holdings
NMR
$28.5B
| $409K | ﹤0.01% |
63,651
+2,010
| +3% | +$11.2K |
|
3416
Carter Bankshares
CARE
$792M
| $408K | ﹤0.01% |
32,270
-4,147
| -11% | -$56.5K |
|
3417
Li Auto
LI
$13.4B
| $407K | ﹤0.01% |
+13,431
| New | +$445K |
|
3418
Civista Bancshares
CIVB
$605M
| $405K | ﹤0.01% |
26,320
-138
| -0.5% | -$2.21K |
|
3419
BNY Mellon High Yield Beta ETF
BKHY
$161M
| $405K | ﹤0.01% |
+8,489
| New | +$402K |
|
3420
BlackRock Science and Technology Term Trust
BSTZ
$2.05B
| $404K | ﹤0.01% |
20,842
-37,689
| -64% | -$677K |
|
3421
Invesco Advantage Municipal Income Trust II
VKI
$398M
| $403K | ﹤0.01% |
47,468
-33,333
| -41% | -$284K |
|
3422
First Busey Corp
BUSE
$2.63B
| $402K | ﹤0.01% |
16,716
-18,250
| -52% | -$428K |
|
3423
Aegon
AEG
$13.9B
| $400K | ﹤0.01% |
66,157
-3,991
| -6% | -$23.2K |
|
3424
Amplify Online Retail ETF
IBUY
$112M
| $397K | ﹤0.01% |
6,839
-132
| -2% | -$7.09K |
|
|
EAD
3425
Allspring Income Opportunities Fund
EAD
$378M
| $397K | ﹤0.01% |
59,688
-30,313
| -34% | -$201K |
|
Similar funds
Ameriprise's Q1 2024 Portfolio in Review
As of Q1 2024, Ameriprise held 4,016 positions worth $363B, up 8.8% from $334B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Ameriprise's Q1 2024 filing shows 118 new, 1,585 increased, 2,002 reduced and 175 closed positions. Its largest new stake was Arcadium Lithium plc: 13,685,562 shares worth $59M. The largest sale was Lam Research, an estimated $669M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2024 buy was Arcadium Lithium plc: 13,685,562 shares worth $59M.
- Ameriprise added most to Meta Platforms (Facebook) in Q1 2024, an estimated $778M increase.
- Ameriprise's biggest Q1 2024 reduction was Lam Research, cutting an estimated $669M.
- Ameriprise fully exited Livent Corporation in Q1 2024, selling an estimated $120M.
- Ameriprise's ten largest holdings make up 18% of its $363B portfolio in Q1 2024.
- Ameriprise opened 118 new positions and closed 175 in Q1 2024.
- Ameriprise's portfolio value rose 8.8% quarter-over-quarter to $363B.
Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.